Based on the three immune subgroups in ESCC, we found that CTLA4 and HAVCR2 (TIM-3) were significantly upregulated in subgroups II and III (Figures 4(a) and 4(b)). This evidence concerns the gene CTLA4 and esophageal squamous cell carcinoma.